Furthermore, in gastric cancer, we have validated the recent findings from Laitinen et al. [26] of a negative prognostic impact of PODXL expression, even though the proportion of PODXL negative gastric cancer cases were lower in our study (21.5 % compared to 42.5 %). This evidence concerns the gene PODXL and gastric cancer.